Hear Life Science and Research perspectives from our esteemed industry panel on the value and use of radiomics in clinical trials and drug development. https://t.co/Uj9nmNL9Y2
#radiomics#clinicaltrials
Read the conclusion to our Radiomics in Action eBook. Learn how radiomics is useful to researchers and trial sponsors to help identify which patients should be included in trials, and which type of patients are the most likely to benefit from those trials
https://t.co/uDgfUUS6se
HealthMyne's CEO Rose Higgins talks about what Radiomics is and takes a look at some real-world examples of how radiomics is being used today in clinical trials and academic research. Read the article now.
https://t.co/cCa2W8URc7
#Radiomics#ClinicalTrials
Download Chapter 1 of our eBook, Radiomics In Action. Realize the benefits radiomics insights play in translating research into personalized treatment.
https://t.co/31FhMHKiyW
#radiomics#precisionmedicine#personalizedcare
Radiomics and its application to oncology is at a turning point and can be utilized through proper data utilization. Robert Holmes, Ph.D., Chief Science Officer of HealthMyne discusses the 3 challenges that must be solved before widespread adoption occurs.
https://t.co/6iK7Pjw4CP
Rose Higgins, CEO of HealthMyne discusses Radiomics, the science of Advanced imaging analytics in this article from @DrugDiscoverDev
https://t.co/XD6s62OJmB
#radiomics
Read the special report from @MGMA and 21 industry leaders who give their insight into what healthcare leaders should expect in trends this year. HealthMyne's CEO Rose Higgins discusses the rise of multi-omics in personalizing treatments for patients.
https://t.co/x0GpTHwekC
Watch the HealthMyne & @Flywheel CEO Fireside Chat video to learn how to unlock the power of radiomic data within your imaging data curation and analytics pipeline.
https://t.co/OlDFpgN3nn
Read our 2022 prediction in @healthitanswers Answers for AI and Radiomics. Rose Higgins, CEO of HealthMyne joins other industry thought leaders to share insights and perspectives on what the AI and Analytics landscape will look like in the year ahead.
https://t.co/2flLIDuA0n
Rose Higgins, CEO of HealthMyne shares her prediction for Pharma in 2022. Read the full article in Drug Discovery & Development to learn how radiomics adoption continues to gain steam in drug development.
https://t.co/GZjOJSRqs2
#Radiomics#DrugDiscovery#AcceleratingResearch
It's not too late to register for the HealthMyne & @Flywheel_io Fireside Chat: CEO Perspectives on the Value of an Integrated Platform for Radiomic Data Management and Analysis. Tomorrow 12/16/21 @ 2pm ET.
https://t.co/dSguH61fTY
#radiomics#imagingdata#acceleratingresearch
Download the industry brief from our industry panel highlighting perspectives from academic, research and life sciences on the value of radiomics in clinical trials, drug discovery and therapy response.
https://t.co/ihjbRhGTvb
Join us to hear perspectives from @Flywheel_io and HealthMyne’s CEOs on the value of our seamless end-to-end radiomic data management and analysis platform. Register now for the fireside chat December 16th 2pmET
https://t.co/D7nBg4iNeT
#radiomics#imagingdata
Read the recently published research in AJRCCM from Vanderbilt University Medical Center. HealthMyne is thrilled to have our radiomic solution leveraged as part of this innovative biomarker research to demonstrate clinical value for patient management.
https://t.co/GVOEu0pjbq